{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:54:46Z","timestamp":1700625286180},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,1,23]],"date-time":"2006-01-23T00:00:00Z","timestamp":1137974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,1,23]],"date-time":"2006-01-23T00:00:00Z","timestamp":1137974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1038\/sj.bmt.1705267","type":"journal-article","created":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T09:34:27Z","timestamp":1138181667000},"page":"511-515","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation"],"prefix":"10.1038","volume":"37","author":[{"given":"C-K","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Zangari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Fassas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Thertulien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Talamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Badros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cottler-Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"van Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Barlogie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Tricot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,23]]},"reference":[{"key":"BF1705267_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0037-1963(01)90016-2","volume":"38","author":"W Bensinger","year":"2001","unstructured":"Bensinger W, Maloney D, Storb R . Allogeneic hematopoietic cell transplantation for multiple myeloma. Semin Hematol 2001; 38: 243\u2013249.","journal-title":"Semin Hematol"},{"key":"BF1705267_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1182\/blood-2003-04-1045","volume":"103","author":"B Barlogie","year":"2004","unstructured":"Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E et al. Treatment of multiple myeloma. Blood 2004; 103: 20\u201332.","journal-title":"Blood"},{"key":"BF1705267_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2141.2001.02726.x","volume":"113","author":"G Gahrton","year":"2001","unstructured":"Gahrton G, Svensson H, Cavo M, Apperly J, Bacigalupo A, Bjorkstrand B et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983\u201393 and 1994\u20138 at European Group for Blood and Marrow Transplantation centres. Br J Haematol 2001; 113: 209\u2013216.","journal-title":"Br J Haematol"},{"key":"BF1705267_CR4","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1182\/blood-2004-06-2387","volume":"105","author":"C Crawley","year":"2005","unstructured":"Crawley C, Lalancette M, Szydlo R, Gilleece M, Peggs K, Mackinnon S et al. Outcomes for reduced intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the chronic leukemia working party of the EBMT. Blood 2005; 105: 4532\u20134539.","journal-title":"Blood"},{"key":"BF1705267_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.bbmt.2004.06.002","volume":"10","author":"N Kroger","year":"2004","unstructured":"Kroger N, Perez-Simon JA, Myint H, Klingemann H, Shimoni A, Nagler A et al. Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan\/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma. Biol Blood Marrow Transplant 2004; 10: 698\u2013708.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705267_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0301-472X(02)01010-X","volume":"31","author":"CK Lee","year":"2003","unstructured":"Lee CK, Badros A, Barlogie B, Morris C, Zangari M, Fassas A et al. Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning. Exp Hematol 2003; 31: 73\u201380.","journal-title":"Exp Hematol"},{"key":"BF1705267_CR7","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1182\/blood-2002-04-1150","volume":"100","author":"N Kroger","year":"2002","unstructured":"Kroger N, Sayer HG, Schwerdtfeger R, Kiehl M, Nagler A, Renges H et al. Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality. Blood 2002; 100: 3919\u20133924.","journal-title":"Blood"},{"key":"BF1705267_CR8","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMoa032290","volume":"349","author":"M Attal","year":"2003","unstructured":"Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003; 349: 2495\u20132502.","journal-title":"N Engl J Med"},{"key":"BF1705267_CR9","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1182\/blood-2002-09-2873","volume":"101","author":"J Shaughnessy","year":"2003","unstructured":"Shaughnessy J, Jacobson J, Sawyer J, McCoy J, Fassas A, Zhan F et al. Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression. Blood 2003; 101: 3849\u20133856.","journal-title":"Blood"},{"key":"BF1705267_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V93.1.55","volume":"93","author":"B Barlogie","year":"1999","unstructured":"Barlogie B, Jagannath S, Desikan KR, Mattox S, Vesole D, Siegel D et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999; 93: 55\u201365.","journal-title":"Blood"},{"key":"BF1705267_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1200\/JCO.2002.20.5.1295","volume":"20","author":"A Badros","year":"2002","unstructured":"Badros A, Barlogie B, Siegel E, Cottler-Fox M, Zangari M, Fassas A et al. Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning. J Clin Oncol 2002; 20: 1295\u20131303.","journal-title":"J Clin Oncol"},{"key":"BF1705267_CR12","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1182\/blood.V92.11.4269","volume":"92","author":"JR Sawyer","year":"1998","unstructured":"Sawyer JR, Lukacs JL, Munshi N, Desikan KR, Singhal S, Mehta J et al. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood 1998; 92: 4269\u20134278.","journal-title":"Blood"},{"key":"BF1705267_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695\u2013706.","journal-title":"Stat Med"},{"key":"BF1705267_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observation. JASA 1958; 53: 457\u2013481.","journal-title":"JASA"},{"key":"BF1705267_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4899-3115-3","volume-title":"Modelling Survival Data in Medical Research","author":"D. Collett","year":"1994","unstructured":"Collett D . Modeling Survival Data in Medical Research. Chapman and Hall: London, 1994."},{"key":"BF1705267_CR16","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1182\/blood-2003-11-3862","volume":"103","author":"HM Lokhorst","year":"2004","unstructured":"Lokhorst HM, Wu K, Verdonck LF, Laterveer LL, van de Donk NW, van Oers MH, et al. The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma. Blood 2004; 103: 4362\u20134364.","journal-title":"Blood"},{"key":"BF1705267_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1182\/blood.V98.4.934","volume":"98","author":"E Alyea","year":"2001","unstructured":"Alyea E, Weller E, Schlossman R, Canning C, Webb I, Doss D et al. T-cell\u2013depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect. Blood 2001; 98: 934\u2013939.","journal-title":"Blood"},{"key":"BF1705267_CR18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/nm1202-797","volume":"8","author":"C Schmaltz","year":"2002","unstructured":"Schmaltz C, Alpdogan O, Kappel BJ, Muriglan SJ, Rotolo JA, Ongchin J et al. T cells require TRAIL for optimal graft-versus-tumor activity. Nat Med 2002; 8: 1433\u20131437.","journal-title":"Nat Med"},{"key":"BF1705267_CR19","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1182\/blood.V97.9.2886","volume":"97","author":"C Schmaltz","year":"2001","unstructured":"Schmaltz C, Alpdogan O, Horndasch KJ, Muriglan SJ, Kappel BJ, Teshima T et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 2001; 97: 2886\u20132895.","journal-title":"Blood"},{"key":"BF1705267_CR20","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","volume":"64","author":"R Fonseca","year":"2004","unstructured":"Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M et al. Genetics and cytogenetics of multiple myeloma: A workshop report. Cancer Research 2004; 64: 1546\u20131558.","journal-title":"Cancer Research"},{"key":"BF1705267_CR21","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V95.12.4008","volume":"95","author":"R Desikan","year":"2000","unstructured":"Desikan R, Barlogie B, Sawyer J, Ayers D, Tricot G, Badros A et al. Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood 2000; 95: 4008\u20134010.","journal-title":"Blood"},{"key":"BF1705267_CR22","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1182\/blood.V98.7.2229","volume":"98","author":"NV Smadja","year":"2001","unstructured":"Smadja NV, Bastard C, Brigaudeau C, Leroux D, Fruchart C . Hypodiploidy is a major prognostic factor in multiple myeloma. Blood 2001; 98: 2229\u20132238.","journal-title":"Blood"},{"key":"BF1705267_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1046\/j.1365-2141.2002.03757.x","volume":"118","author":"AB Fassas","year":"2002","unstructured":"Fassas AB, Spencer T, Sawyer J, Zangari M, Lee CK, Anaissie E et al. Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma. Br J Haematol 2002; 118: 1041\u20131047.","journal-title":"Br J Haematol"},{"key":"BF1705267_CR24","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1182\/blood-2003-12-4435","volume":"103","author":"N Kroger","year":"2004","unstructured":"Kroger N, Schilling G, Einsele H, Liebisch P, Shimoni A, Nagler A et al. Deletion of chromosome band 13q14 detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose reduced stem cell transplantation. Blood 2004; 103: 4056\u20134061.","journal-title":"Blood"},{"key":"BF1705267_CR25","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1182\/blood-2002-11-3514","volume":"101","author":"N Mitsiades","year":"2003","unstructured":"Mitsiades N, Mitsiades CS, Richardson PG, McMullan C, Poulaki V, Fanourakis G et al. Molecular sequelae of histone deacetylase inhibition in human malignant B cells. Blood 2003; 101: 4055\u20134062.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:49:27Z","timestamp":1648082967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,23]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,3,1]]}},"alternative-id":["BF1705267"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705267","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,23]]},"assertion":[{"value":"31 August 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}